
ADAG Valuation
Adagene Inc
- Overview
- Forecast
- Valuation
- Earnings
ADAG Relative Valuation
ADAG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ADAG is overvalued; if below, it's undervalued.
Historical Valuation
Adagene Inc (ADAG) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.36. The fair price of Adagene Inc (ADAG) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:2.13
Fair
-2.34
PE
1Y
3Y
5Y
Trailing
Forward
-1.11
EV/EBITDA
Adagene Inc. (ADAG) has a current EV/EBITDA of -1.11. The 5-year average EV/EBITDA is -1.44. The thresholds are as follows: Strongly Undervalued below -8.05, Undervalued between -8.05 and -4.74, Fairly Valued between 1.87 and -4.74, Overvalued between 1.87 and 5.17, and Strongly Overvalued above 5.17. The current Forward EV/EBITDA of -1.11 falls within the Historic Trend Line -Fairly Valued range.
-1.18
EV/EBIT
Adagene Inc. (ADAG) has a current EV/EBIT of -1.18. The 5-year average EV/EBIT is -1.35. The thresholds are as follows: Strongly Undervalued below -8.12, Undervalued between -8.12 and -4.73, Fairly Valued between 2.04 and -4.73, Overvalued between 2.04 and 5.43, and Strongly Overvalued above 5.43. The current Forward EV/EBIT of -1.18 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Adagene Inc. (ADAG) has a current PS of 0.00. The 5-year average PS is 17.17. The thresholds are as follows: Strongly Undervalued below -36.83, Undervalued between -36.83 and -9.83, Fairly Valued between 44.18 and -9.83, Overvalued between 44.18 and 71.18, and Strongly Overvalued above 71.18. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-3.00
P/OCF
Adagene Inc. (ADAG) has a current P/OCF of -3.00. The 5-year average P/OCF is -2.01. The thresholds are as follows: Strongly Undervalued below -7.27, Undervalued between -7.27 and -4.64, Fairly Valued between 0.62 and -4.64, Overvalued between 0.62 and 3.25, and Strongly Overvalued above 3.25. The current Forward P/OCF of -3.00 falls within the Historic Trend Line -Fairly Valued range.
-2.75
P/FCF
Adagene Inc. (ADAG) has a current P/FCF of -2.75. The 5-year average P/FCF is -2.53. The thresholds are as follows: Strongly Undervalued below -8.37, Undervalued between -8.37 and -5.45, Fairly Valued between 0.40 and -5.45, Overvalued between 0.40 and 3.32, and Strongly Overvalued above 3.32. The current Forward P/FCF of -2.75 falls within the Historic Trend Line -Fairly Valued range.
Adagene Inc (ADAG) has a current Price-to-Book (P/B) ratio of 2.65. Compared to its 3-year average P/B ratio of 1.40 , the current P/B ratio is approximately 89.64% higher. Relative to its 5-year average P/B ratio of 1.55, the current P/B ratio is about 70.71% higher. Adagene Inc (ADAG) has a Forward Free Cash Flow (FCF) yield of approximately -27.37%. Compared to its 3-year average FCF yield of -21.31%, the current FCF yield is approximately 28.48% lower. Relative to its 5-year average FCF yield of -14.96% , the current FCF yield is about 82.93% lower.
2.65
P/B
Median3y
1.40
Median5y
1.55
-27.37
FCF Yield
Median3y
-21.31
Median5y
-14.96
Competitors Valuation Multiple
The average P/S ratio for ADAG's competitors is 42.65, providing a benchmark for relative valuation. Adagene Inc Corp (ADAG) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ADAG increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ADAG in the past 1 year is driven by Unknown.
People Also Watch

EDAP
Edap Tms SA
2.260
USD
+24.18%

CNF
CNFinance Holdings Ltd
0.410
USD
0.00%

SKYE
Skye Bioscience Inc
3.500
USD
+0.57%

CBAT
CBAK Energy Technology Inc
0.930
USD
+1.53%

VTGN
Vistagen Therapeutics Inc
3.340
USD
+3.41%

DIT
Amcon Distributing Co
119.990
USD
+3.56%

AMTD
AMTD IDEA Group
1.040
USD
0.00%

METCB
Ramaco Resources Inc
16.250
USD
-0.49%
FAQ

Is Adagene Inc (ADAG) currently overvalued or undervalued?
Adagene Inc (ADAG) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.36. The fair price of Adagene Inc (ADAG) is between to according to relative valuation methord.

What is Adagene Inc (ADAG) fair value?

How does ADAG's valuation metrics compare to the industry average?

What is the current P/B ratio for Adagene Inc (ADAG) as of Sep 01 2025?

What is the current FCF Yield for Adagene Inc (ADAG) as of Sep 01 2025?

What is the current Forward P/E ratio for Adagene Inc (ADAG) as of Sep 01 2025?
